
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current N4P market cap is 2.15M. The company's latest EPS is GBP -0.0020 and P/E is -2.00.
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 0 | 0 | 0 | 2k | 7k |
Operating Income | -1.56M | -1.84M | -1.19M | -1.34M | -1.22M |
Net Income | -1.31M | -1.54M | -1.03M | -1.27M | -1.06M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 3.83M | 2.34M | 2.17M | 1.28M | 776k |
Total Liabilities | 169k | 212k | 78k | 81k | 124k |
Total Equity | 3.66M | 2.13M | 2.09M | 1.19M | 652k |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -1.38M | -1.77M | -828k | -1.21M | -971k |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 3.97M | 1,000 | 964k | 316k | 570k |
Market Cap | 2.15M |
Price to Earnings Ratio | -2.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.33 |
Price to Book Ratio | 3.3 |
Dividend Yield | - |
Shares Outstanding | 537.56M |
Average Volume (1 week) | 2.65M |
Average Volume (1 Month) | 1.24M |
52 Week Change | -23.81% |
52 Week High | 0.80 |
52 Week Low | 0.375 |
Spread (Intraday) | 0.1 (22.22%) |
Company Name | N4 Pharma Plc |
Address |
c/o arch law limited huckletree bishopsgate london EC2N 4BQ |
Website | https://www.n4pharma.com/ |
Industry | computer & office equipment (3570) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions